A. Varricchio

发表

Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.

H. Suryapranata, G. De Luca, T. Lanzillo, 2014, JACC. Cardiovascular interventions.

Letter regarding "Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI".

A. Varricchio, E. Moscarella, F. Granata, 2015, International journal of cardiology.

Prevention of recurrent respiratory infections

A. Palamara, G. Marseglia, L. Pignataro, 2021, Italian Journal of Pediatrics.

One-year results following a pre-specified ABSORB implantation strategy in ST-elevation myocardial infarction (BVS STEMI STRATEGY-IT study).

G. Campo, S. Brugaletta, A. Ielasi, 2019, Cardiovascular revascularization medicine : including molecular interventions.

A Prospective Evaluation of a Pre-Specified Absorb BVS Implantation Strategy in ST-Segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Study.

G. Campo, S. Brugaletta, A. Ielasi, 2017, JACC. Cardiovascular interventions.

A prospective evaluation of a standardized strategy for the use of a polymeric everolimus‐eluting bioresorbable scaffold in ST‐segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY‐IT study

G. Campo, S. Brugaletta, A. Ielasi, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience

A. Colombo, A. Ielasi, A. Tanaka, 2016, Circulation. Cardiovascular interventions.

Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry.

F. Borgia, B. Trimarco, G. Galasso, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI STRATEGY-IT long-term

Bruno Loi, G. Campo, S. Brugaletta, 2021, Journal of cardiovascular medicine.

Registro Absorb Italiano (BVS-RAI): an investigators-owned and -directed, open, prospective registry of consecutive patients treated with the Absorb™ BVS: study design.

G. Tognoni, Bruno Loi, A. Ielasi, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience.

A. Colombo, B. Trimarco, G. Esposito, 2015, International journal of cardiology.

Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for preventing recurrent acute otitis media in children: a real-life clinical experience

G. Ciprandi, A. Varricchio, I. La Mantia, 2017, International journal of general medicine.

Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre "Registro ABSORB Italiano" (RAI registry).

A. Ielasi, B. Cortese, A. Varricchio, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

One‐year clinical performance of ABSORB bioresorbable vascular scaffold in patients presenting with acute coronary syndromes: Results from the RAI registry

A. Durante, P. Calabrò, A. Ielasi, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes.

G. De Luca, F. Piscione, G. Galasso, 2018, The American journal of cardiology.

Are acute coronary syndromes an ideal scenario for bioresorbable vascular scaffold implantation?

R. De Rosa, G. Campo, E. Cerrato, 2017, Journal of thoracic disease.

"Full-plastic jacket" with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413).

A. Durante, P. Calabrò, G. Tarantini, 2018, International journal of cardiology.

Intranasal Flunisolide Treatment in Children with Adenoidal Hypertrophy

G. Marseglia, C. Capristo, G. Ciprandi, 2007, International journal of immunopathology and pharmacology.

Hypertonic Saline Solution in Children with Adenoidal Hyperytrophy: Preliminary Evidence

G. Ciprandi, M. Di Gioacchino, A. Varricchio, 2007 .

Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry).

R. Latini, A. Durante, P. Calabrò, 2017, The American journal of cardiology.

Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors and BMS or DES

E. D. Lorenzo, T. Lanzillo, F. Manganelli, 2010, Journal of Thrombosis and Thrombolysis.

Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study.

G. Campo, S. Brugaletta, M. Sabaté, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry).

A. Durante, P. Calabrò, A. Ielasi, 2018, International journal of cardiology.

Bioresorbable Vascular Scaffolds in In-Stent Restenosis.

A. Ielasi, A. Varricchio, E. Moscarella, 2018, JACC. Cardiovascular interventions.

Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak

D. Bruzzese, B. Villari, E. Russolillo, 2020, Circulation.

Prevention of Recurrent Upper Respiratory Tract Infections in a Community of Cloistered Nuns Using a New Immunostimulating Bacterial Lysate

A. Varricchio, S. D'Ambrosio, G. Motta, 2004, Arzneimittelforschung.

Hypertonic Saline is More Effective Than Normal Saline in Seasonal Allergic Rhinitis in Children

S. Esposito, N. Principi, P. Capaccio, 2012, International journal of immunopathology and pharmacology.

Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS‐save registry

R. Latini, A. Ielasi, B. Cortese, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Peripheral Eosinophil Counts Correlate With Nasal Eosinophil Counts in Patients With Rhinitis.

G. Ciprandi, G. Tajana, A. Varricchio, 2018, Journal of investigational allergology & clinical immunology.

Inflammation in Respiratory Allergy Treated by Sublingual Immunotherapy

M. Mauro, M. Russello, F. Frati, 2009 .

Intranasal Flunisolide Treatment in Patients with Non-Allergic Rhinitis

G. Ciprandi, A. Varricchio, A. De Lucia, 2011, International journal of immunopathology and pharmacology.

First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.

A. Ielasi, B. Cortese, A. Varricchio, 2017, Coronary artery disease.

Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions.

E. Romagnoli, G. Tognoni, A. Ielasi, 2015, The American journal of cardiology.

One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry).

A. Durante, P. Calabrò, A. Ielasi, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

TCT-425 Bioresorbable vascular scaffold technology for small vessel coronary artery disease: results from the Italian multicenter RAI Registry.

A. Durante, P. Calabrò, A. Ielasi, 2016, Journal of the American College of Cardiology.

Vitamin D 3 plus Lactobacillus reuteri DSM 17938 as Adjuvant for Allergen Immunotherapy : A Preliminary Experience

G. Ciprandi, A. Varricchio, 2015 .

Noninvasive assessment of left and right internal mammary artery graft patency with high-frequency transthoracic echocardiography.

M. Scherillo, P. Caso, A. D’Andrea, 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

When rhinosinusitis is not just rhinosinusitis: clinical characteristics and phenotypes of patients with type 2 chronic rhinosinusitis with nasal polyps

G. Ciprandi, A. Varricchio, I. La Mantia, 2022, Acta bio-medica : Atenei Parmensis.

The relevance of the Mometasone furoate nasal spray in clinical practice.

G. Ciprandi, A. Varricchio, 2018, Journal of biological regulators and homeostatic agents.

Inter-society consensus for the use of inhaled corticosteroids in infants, children and adolescents with airway diseases

G. Pajno, A. Kantar, A. Licari, 2021, Italian Journal of Pediatrics.

Sinuclean Nebules treatment in children suffering from otitis media with effusion.

G. Ciprandi, A. Varricchio, A. Della Volpe, 2017, International journal of pediatric otorhinolaryngology.

Inflammation, infection, and allergy of upper airways: new insights from national and real-world studies

G. Ciprandi, A. Varricchio, I. La Mantia, 2020, Italian Journal of Pediatrics.

The nose and paranasal sinuses.

G. Ciprandi, G. Tortoriello, A. Varricchio, 2010, International journal of immunopathology and pharmacology.

Inhaled tobramycin in children with acute bacterial rhinopharyngitis.

G. Marseglia, G. Ciprandi, G. Sabatino, 2006, International journal of immunopathology and pharmacology.

Development of an algorithm for the management of cervical lymphadenopathy in children: consensus of the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Society of Pediatric Infectious Diseases and the Italian Society of Pediatric Otorhinolaryngology

M. Paulli, I. Sardi, G. Marseglia, 2015, Expert review of anti-infective therapy.

Inhaled Thiamphenicol and Acetilcysteine in Children with Acute Bacterial Rhinopharyngitis

G. Ciprandi, M. Di Gioacchino, A. Varricchio, 2008, International journal of immunopathology and pharmacology.

Chondroid Chordoma of the Lateral Skull Base

A. Baldi, A. Varricchio, R. Rossiello, 2001, ORL.

Prevention of surgery in children with adenoidal hypertrophy treated with intranasal flunisolide: a 12-month follow-up.

G. Ciprandi, G. Tortoriello, M. Di Gioacchino, 2009, Journal of biological regulators and homeostatic agents.

Allergen immunotherapy in children with otitis media with effusion: a preliminary experience.

G. Ciprandi, A. Varricchio, I. La Mantia, 2020, European annals of allergy and clinical immunology.

Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.

G. De Luca, T. Lanzillo, F. Manganelli, 2009, American heart journal.

The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.

G. De Luca, T. Lanzillo, F. Manganelli, 2009, JACC. Cardiovascular interventions.

CORONARY INTERVENT IONS

A. Ielasi, B. Cortese, A. Varricchio, 2015 .

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Marco Valgimigli, Adnan Kastrati, Christoph Kaiser, 2007, European heart journal.

Bioresorbable Vascular Scaffold: A Pioneering Solution for In-Stent Restenosis of stent fracture on right coronary artery

L. Caliendo, A. Varricchio, E. Moscarella, 2016 .

Coronary In-stent restenosis : Where are we Now ?

A. Ielasi, B. Cortese, A. Varricchio, 2016 .

Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experience

G. Ciprandi, A. Varricchio, A. Della Volpe, 2014, Italian Journal of Pediatrics.

Choosing nasal devices: a dilemma in clinical practice

G. Ciprandi, A. Varricchio, I. La Mantia, 2023, Acta bio-medica : Atenei Parmensis.

Nasal application of immunotherapy.

A. Varricchio, A. De Lucia, G. Motta, 2003, Chemical immunology and allergy.

Clinical outcomes of overlapping versus non‐overlapping everolimus‐eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413)

A. Durante, P. Calabrò, A. Ielasi, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Atypical "vacuum" inside of neoatherosclerosis long term after DES implantation: insights from optical coherence tomography.

P. Calabrò, R. Bianchi, M. Russo, 2015, International journal of cardiology.

Smell recovery in patients with COVID-19: an experience with nebulized nasal treatment.

G. Ciprandi, A. Varricchio, I. La Mantia, 2021, Journal of biological regulators and homeostatic agents.

Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.

G. De Luca, T. Lanzillo, F. Manganelli, 2009, Circulation.

Bioresorbable vascular scaffold versus everolimus‐eluting stents or drug eluting balloon for the treatment of coronary in‐stent restenosis: 1‐Year follow‐up of a propensity score matching comparison (the BIORESOLVE‐ISR Study)

A. Colombo, P. Calabrò, A. Ielasi, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Absorb bioresorbable vascular scaffold vs. everolimus‐eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD‐ABSORB studies

P. Smits, A. Ielasi, G. Tarantini, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution?

A. Varricchio, E. Moscarella, F. Granata, 2015, Coronary artery disease.

Rationale and Design of the PARTHENOPE Trial: A Two-by-Two Factorial Comparison of Polymer-Free vs. Biodegradable-Polymer Drug-Eluting Stents and Personalized vs. Standard Duration of Dual Antiplatelet Therapy in All-Comers Undergoing PCI.

E. Russolillo, R. Piccolo, P. Calabrò, 2023, American heart journal.

ImpaCt of an optimal Implantation strategy on Absorb long-term Outcomes: the CIAO Registry.

A. Colombo, M. De Carlo, E. Cerrato, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience

A. Colombo, A. Ielasi, A. Tanaka, 2016, Circulation. Cardiovascular interventions.

Impact of allergic rhinitis on asthma in children: effects on bronchodilation test

A. Varricchio, Michele Capasso, Giorgio Ciprandi, 2010, Allergy.

Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential Breakthrough

A. Di Minno, A. Zicari, A. Varricchio, 2024, Nutrients.